SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2015Bright Prospects for J&J Psoriasis Drug Posted by Shirley S. Wang [HEALTH BIcebrg-6/17/2008
2014Agenda: On June 17, 2008, the [FDA advisory] committee will discuss biologic liIcebrg-6/16/2008
2013Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined bIcebrg-6/15/2008
2012FDA Says J&J Psoriasis Drug Could Increase Cancer Risk By John Wolper 09:06,Icebrg-6/14/2008
2011Item 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a ProvIcebrg-6/12/2008
2010AVANT Announces Vaccine Adjuvant Licenses with 3M Wednesday June 11, 8:00 am ET Icebrg-6/11/2008
2009Phase 3 data show efficacy of golimumab in RA patients previously treated with aIcebrg-6/11/2008
2008Influence of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4) Common PolymorpIcebrg-6/7/2008
2007NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic Icebrg-6/4/2008
2006Medarex shares fall on concerns over melanoma data Associated Press 06.02.08, 7:Icebrg-6/4/2008
2005PD-1 Expression and IL-2 Loss of Cytomegalovirus- Specific T Cells Correlates wiIcebrg-6/4/2008
2004Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 AntibodyIcebrg-6/2/2008
2003Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and IncreasedIcebrg-6/1/2008
2002New Ipilimumab Survival Data in Patients with Metastatic Melanoma Presented at AIcebrg-6/1/2008
2001Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206Icebrg-6/1/2008
2000Concurrent decrease in IL-10 with development of immune-related adverse events iIcebrg-5/29/2008
1999Surgeon's trial study on cancer is hailed Brain tumor took his life, but hisIcebrg-5/28/2008
1998Medarex Reports Phase 1 Clinical Data of MDX-1100 at Digestive Disease Week WednIcebrg-5/21/2008
1997They all disappeared rather quietly. They were used for some time for investor bIcebrg-5/18/2008
1996Probably the best move Drakeman ever made. Out of curiosity, what happened to thrkrw-5/18/2008
1995Medarex Launches Human Antibody Business [A blast from the past. I came acrossIcebrg-5/18/2008
1994Medarex, Inc. (MEDX) – Buy (was Hold) MEDX: Upgrading to BUY with $11 PT, Based Icebrg-5/17/2008
1993Some comment from UBS' analyst Jeff Elliott to the ipilimumab-related abstraIcebrg-5/16/2008
1992Novel efficacy criteria for antitumor activity to immunotherapy using the examplIcebrg-5/16/2008
1991Here is a report on a competing PD-1 antibody I was not aware of: clincancerresPseudo Biologist-5/15/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News